Getinge has provided a detailed breakdown of the shortage, stating that it is not yet clear when it may be over. The FDA said it will keep a close eye on the situation and provide updates when possible.
This latest recall involves the device's driveline boot cover, which “can become stiff over time” and cause problems for clinicians. There have been 33 complaints since 2017 related to the issue.
The new-look device gained CE mark approval in Europe in 2020, but it has not been approved yet in the United States.
Researchers examined data from more than 900 patients, presenting their findings in the Journal of the American Heart Association.
The authors of a new commentary in the American Journal of Cardiology argued that well-balanced plant-based diets are good for the heart and good for society as a whole.
Nontraditional risk factors such as dementia, PTSD, bipolar disorder and low socioeconomic status are all important to consider when patients are candidates for aortic valve replacement.
Read our recap of some of the biggest FDA-related stories that impacted cardiology in the last month.
Physicians are now bracing for payment cuts after the Centers for Medicare and Medicaid Services (CMS) published its final rule for the 2023 Physician Fee Schedule.
Bhvita Jani, research manager, Signify Research, explains key trends and technology advances in the computed tomography (CT) market.